Literature DB >> 19109488

Control of motoneuron survival by angiogenin.

Dairín Kieran1, Jordi Sebastia, Matthew J Greenway, Matthew A King, Dervla Connaughton, Caoimhin G Concannon, Beau Fenner, Orla Hardiman, Jochen H M Prehn.   

Abstract

Mutations in the hypoxia-inducible factor angiogenin (ANG) have been identified in Amyotrophic Lateral Sclerosis (ALS) patients, but the potential role of ANG in ALS pathogenesis was undetermined. Here we show that angiogenin promotes motoneuron survival both in vitro and in vivo. Angiogenin protected cultured motoneurons against excitotoxic injury in a PI-3-kinase/Akt kinase-dependent manner, whereas knock-down of angiogenin potentiated excitotoxic motoneuron death. Expression of wild-type ANG protected against endoplasmic reticulum (ER) stress-induced and trophic-factor-withdrawal-induced cell death in vitro, whereas the ALS-associated ANG mutant K40I exerted no protective activity and failed to activate Akt-1. In SOD1(G93A) mice angiogenin delivery increased lifespan and motoneuron survival, restored the disease-associated decrease in Akt-1 survival signaling, and reversed a pathophysiological increase in ICAM-1 expression. Our data demonstrate that angiogenin is a key factor in the control of motoneuron survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19109488      PMCID: PMC6671464          DOI: 10.1523/JNEUROSCI.3399-08.2008

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  85 in total

Review 1.  Neurovascular pathways to neurodegeneration in Alzheimer's disease and other disorders.

Authors:  Berislav V Zlokovic
Journal:  Nat Rev Neurosci       Date:  2011-11-03       Impact factor: 34.870

Review 2.  RNA processing pathways in amyotrophic lateral sclerosis.

Authors:  Marka van Blitterswijk; John E Landers
Journal:  Neurogenetics       Date:  2010-03-27       Impact factor: 2.660

Review 3.  Neuroprotection for amyotrophic lateral sclerosis: role of stem cells, growth factors, and gene therapy.

Authors:  Rachna S Pandya; Lilly L J Mao; Edward W Zhou; Robert Bowser; Zhenglun Zhu; Yongjin Zhu; Xin Wang
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2012-03

4.  Human angiogenin presents neuroprotective and migration effects in neuroblastoma cells.

Authors:  Goang-Won Cho; Byung Yong Kang; Seung Hyun Kim
Journal:  Mol Cell Biochem       Date:  2010-02-20       Impact factor: 3.396

5.  A neuroprotective role for angiogenin in models of Parkinson's disease.

Authors:  Trent U Steidinger; David G Standaert; Talene A Yacoubian
Journal:  J Neurochem       Date:  2010-12-22       Impact factor: 5.372

6.  Angiogenin stimulates ribosomal RNA transcription by epigenetic activation of the ribosomal DNA promoter.

Authors:  Jinghao Sheng; Wenhao Yu; Xiangwei Gao; Zhengping Xu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2014-04       Impact factor: 6.384

7.  Transcription of angiogenin and ribonuclease 4 is regulated by RNA polymerase III elements and a CCCTC binding factor (CTCF)-dependent intragenic chromatin loop.

Authors:  Jinghao Sheng; Chi Luo; Yuxiang Jiang; Philip W Hinds; Zhengping Xu; Guo-fu Hu
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

8.  Angiogenin inhibits nuclear translocation of apoptosis inducing factor in a Bcl-2-dependent manner.

Authors:  Shuping Li; Wenhao Yu; Guo-Fu Hu
Journal:  J Cell Physiol       Date:  2012-04       Impact factor: 6.384

9.  Angiogenin-cleaved tRNA halves interact with cytochrome c, protecting cells from apoptosis during osmotic stress.

Authors:  Mridusmita Saikia; Raul Jobava; Marc Parisien; Andrea Putnam; Dawid Krokowski; Xing-Huang Gao; Bo-Jhih Guan; Yiyuan Yuan; Eckhard Jankowsky; Zhaoyang Feng; Guo-fu Hu; Marianne Pusztai-Carey; Madhavi Gorla; Naresh Babu V Sepuri; Tao Pan; Maria Hatzoglou
Journal:  Mol Cell Biol       Date:  2014-04-21       Impact factor: 4.272

10.  Decrease in PTEN and increase in Akt expression and neuron size in aged rat spinal cord.

Authors:  Miguel Augusto Rodrigues de Amorim; Luis Miguel Garcia-Segura; Rodolfo Gustavo Goya; Enrique Leo Portiansky
Journal:  Exp Gerontol       Date:  2010-03-27       Impact factor: 4.032

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.